News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

In Alzheimer's, The 'Juggernaut Is Changing Course,' Says TauRx Pharma Chief Exec



7/18/2017 6:17:05 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
As a lifelong follower of the so-called ‘tau hypothesis,' TauRx Therapeutics chief executive Claude Wischik ploughed a lonely furrow for many years.

After the dramatic Phase III failure of Eli Lilly’s (NYSE: LLY) solanezumab late last year, followed by Merck & Co’s (NYSE: MRK) verubecestat in February, his Aberdeen, UK-based research team might have more company.


Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES